<![CDATA[CAR-T has 'landed,' and the gene therapies need a 'bespoke' approach, says Aradigm CEO Will Shrank, M.D.]]>
Cell and gene therapy often get lumped together in a single category, but there are important distinctions between them — and among the gene therapies, says Will Shrank, M.D. It is important to recognize, says Shrank, “that the sickle cell [gene therapy] …